Related references
Note: Only part of the references are listed.Assigning Site of Origin in Metastatic Neuroendocrine Neoplasms: A Clinically Significant Application of Diagnostic Immunohistochemistry
Andrew M. Bellizzi
ADVANCES IN ANATOMIC PATHOLOGY (2013)
Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT Within Patients with Gastroenteropancreatic Neuroendocrine Tumors
Damian Wild et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Carcinoma of unknown primary: key radiological issues from the recent National Institute for Health and Clinical Excellence guidelines
M. B. Taylor et al.
BRITISH JOURNAL OF RADIOLOGY (2012)
Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases
G. Capurso et al.
BRITISH JOURNAL OF SURGERY (2012)
68Ga-DOTANOC PET/CT in Patients With Carcinoma of Unknown Primary of Neuroendocrine Origin
Niraj Naswa et al.
CLINICAL NUCLEAR MEDICINE (2012)
Contemporary nuclear medicine imaging of neuroendocrine tumours
K. K. Wong et al.
CLINICAL RADIOLOGY (2012)
Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours
Levent Kabasakal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
John K. Ramage et al.
GUT (2012)
Cancer of unknown primary site
Nicholas Pavlidis et al.
LANCET (2012)
THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience
Richard P. Baum et al.
THERANOSTICS (2012)
Neuroendocrine carcinoma of unknown primary: A systematic review of the literature and a comparative study with other neuroendocrine tumors
Aikaterini Stoyianni et al.
CANCER TREATMENT REVIEWS (2011)
68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors
Thorsten D. Poeppel et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
F-18-FDG PET/CT as a Diagnostic Tool in Patients with Extracervical Carcinoma of Unknown Primary Site: A Literature Review
Anne Kirstine Hundahl Moller et al.
ONCOLOGIST (2011)
Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: A systematic review
J. de Bresser et al.
EJSO (2010)
Detection of unknown primary neuroendocrine tumours (CUP-NET) using Ga-68-DOTA-NOC receptor PET/CT
Vikas Prasad et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
The Role of Ga-68-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on In-111-DTPA-Octreotide Scintigraphy
Rajaventhan Srirajaskanthan et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Pathologic Evaluation of Unknown Primary Cancer
Karin A. Oien
SEMINARS IN ONCOLOGY (2009)
Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study
Jorgen Johansen et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2008)
The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site
Pascal Seve et al.
CANCER (2007)
Feasibility of sornatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours
G Savelli et al.
NUCLEAR MEDICINE COMMUNICATIONS (2004)
Share Paper
